{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:32:31Z","timestamp":1760056351090,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.diagmicrobio.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:55:16Z","timestamp":1507830916000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus"],"prefix":"10.1016","volume":"90","author":[{"given":"Laura","family":"Bedin Denardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francielli","family":"Pantella Kunz de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica Tairine","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Weiblen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janio","family":"Morais Santurio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Hartz Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","author":"Arendrup","series-title":"Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds","key":"10.1016\/j.diagmicrobio.2017.10.004_bb0005"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0010","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00829-05","article-title":"Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection","volume":"50","author":"Cacciapuoti","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0015","first-page":"292","article-title":"Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191","volume":"129","author":"Graybill","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0020","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/AAC.00833-13","article-title":"Impact of in vivo triazole isolates and echinocandin combination therapy for invasive pulmonary aspergillosis: Enhanced efficacy against CYP51 mutant","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0025","first-page":"1","article-title":"Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis","volume":"19","author":"Martin-Vicente","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0030","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.04469-14","article-title":"The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus","volume":"59","author":"Mavridou","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11908-011-0216-6","article-title":"Current role of echinocandins in the management of invasive aspergillosis","volume":"13","author":"Mikulska","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the checkerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0045","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.35.10.1985","article-title":"Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis","volume":"35","author":"Patterson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis","volume":"68","author":"Seyedmousavi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0055","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/AAC.00053-14","article-title":"Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens","volume":"58","author":"Seyedmousavi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/AAC.00980-12","article-title":"In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0065","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/AAC.48.5.1908-1911.2004","article-title":"Novel inhalational murine model of invasive pulmonary aspergillosis","volume":"48","author":"Sheppard","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2017.10.004_bb0070","first-page":"4","article-title":"Problems in dealing with missing data and informative censoring in clinical trials","volume":"3","author":"Shih","year":"2002","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0075","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1093\/jac\/dkw276","article-title":"Dose optimization of voriconazole\/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic\/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis","volume":"71","author":"Siopi","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1469-0691.2003.00688.x","article-title":"Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive aspergillosis in humans, with a method to test ex vivo synergism","volume":"9","author":"Tascini","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0085","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.01556-08","article-title":"Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin","volume":"5","author":"van de Sande","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.10.004_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11046-013-9719-z","article-title":"Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species","volume":"177","author":"Zhang","year":"2014","journal-title":"Mycopathologia"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317303152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317303152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:51:35Z","timestamp":1760003495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889317303152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0732889317303152"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.10.004","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy of a posaconazole and anidulafungin combination in a murine model of pulmonary aspergillosis due to infection with Aspergillus fumigatus","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}